The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study optimizing the dosing of olaparib tablet formulation combined with cediranib in recurrent ovarian cancer.
 
Joyce Liu
Research Funding - AstraZeneca (Inst); Genentech (Inst); Merrimack (Inst)
 
Jung-min Lee
No Relationships to Disclose
 
Weixiu Luo
No Relationships to Disclose
 
Michael J. Birrer
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
 
Christin Whalen
No Relationships to Disclose
 
Nicole D. Houston
No Relationships to Disclose
 
Elizabeth Obermayer
No Relationships to Disclose
 
Tatum Spagnoletti
No Relationships to Disclose
 
William Thomas Barry
No Relationships to Disclose
 
Elise C. Kohn
No Relationships to Disclose
 
S. Percy Ivy
No Relationships to Disclose
 
Ursula Matulonis
Honoraria - AstraZeneca
Consulting or Advisory Role - Clovis Oncology; Merck KGaA; Momenta Pharmaceuticals